Stock 301257 SMO CLINPLUS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SMO ClinPlus CO.,LTD.

Equities

301257

CNE100005CP8

Healthcare Facilities & Services

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 06/06/2024 BST 		5-day change 1st Jan Change
29.57 CNY +0.85% Intraday chart for SMO ClinPlus CO.,LTD. -10.10% -39.46%
05-30 Smo Clinplus Co.,Ltd. Announces Final Profit Distribution for 2023, Payable on 06 June 2024 CI
05-17 Certain A-Shares of SMO ClinPlus CO.,LTD. are subject to a Lock-Up Agreement Ending on 17-MAY-2024. CI

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 2,922 3,884 2,351 - -
Enterprise Value (EV) 1 2,922 3,884 2,351 2,351 2,351
P/E ratio 36 x 28.6 x 14.5 x 12.2 x 10.5 x
Yield - - 0.34% 0.42% 0.47%
Capitalization / Revenue 4.98 x - 2.58 x 2.21 x 1.94 x
EV / Revenue 4.98 x - 2.58 x 2.21 x 1.94 x
EV / EBITDA - - - - -
EV / FCF - - - - -
FCF Yield - - - - -
Price to Book 3.07 x - 1.91 x 1.66 x 1.44 x
Nbr of stocks (in thousands) 79,268 79,508 79,508 - -
Reference price 2 36.86 48.85 29.57 29.57 29.57
Announcement Date 26/04/23 28/04/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net sales 1 - 586.2 - 912 1,064 1,210
EBITDA - - - - - -
EBIT 1 - 80.87 - 186 222 259
Operating Margin - 13.8% - 20.39% 20.86% 21.4%
Earnings before Tax (EBT) 1 - 80.84 - 186 222 259
Net income 1 57.77 72.41 134.7 161.8 193.1 224.7
Net margin - 12.35% - 17.74% 18.15% 18.57%
EPS 2 0.9846 1.023 1.708 2.038 2.431 2.823
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 2 - - - 0.1000 0.1231 0.1385
Announcement Date 29/04/22 26/04/23 28/04/24 - - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2021 2022 2023 2024 2025 2026
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) - 12.3% - 13.1% 13.6% 13.8%
ROA (Net income/ Total Assets) - 9.25% - 10.6% 11% 11.1%
Assets 1 - 782.5 - 1,527 1,755 2,025
Book Value Per Share 2 - 12.00 - 15.50 17.80 20.50
Cash Flow per Share 2 - - - 1.510 2.070 2.380
Capex 1 - - - 10 10 10
Capex / Sales - - - 1.1% 0.94% 0.83%
Announcement Date 29/04/22 26/04/23 28/04/24 - - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
29.57
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
SMO CLINPLUS CO.,LTD. Stock SMO ClinPlus CO.,LTD.
-39.46% 322M
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-22.13% 7.91B
RADNET, INC. Stock RadNet, Inc.
+76.16% 4.52B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+8.56% 2.74B
SYNLAB AG Stock SYNLAB AG
-2.80% 2.66B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-50.41% 2.02B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-19.59% 1.68B
FLEURY S.A. Stock Fleury S.A.
-20.07% 1.51B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+19.31% 1.24B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-45.78% 1.1B
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. 301257 Stock
  4. Financials SMO ClinPlus CO.,LTD.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW